Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-22 · accession 0001104659-23-025366 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-24 | 2023-02-22 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | A - Grant | $0.00 | +750 | 2,497 | +43% | $0 |
| D | 2023-02-24 | 2023-02-22 | SUPN | Rubin Jonathan | SVP, Chief Medical Off | D - Sale to Iss | $0.00 | -750 | 2,250 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-22 | A | A | 750 | $0.00 | 2,497 | D | — | — | (F1) Includes an aggregate of 247 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
| 2 | Derivative | Restricted Stock Units | 2023-02-22 | D | D | 750 | $0.00 | 2,250 | D | — · — to — | 750 Common Stock | (F2) Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. (F3) These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023. |